# a Non-interventional Study of Sildenafil in the Treatment of Pulmonary Arterial Hypertension (PAH) in Adults From China

> **NCT05546125** · — · COMPLETED · sponsor: **Pfizer Pharmaceuticals Ltd.** · enrollment: 100 (actual)

## Conditions studied

- Pulmonary Arterial Hypertension (PAH)

## Interventions

- **OTHER:** as per Physician's prescription

## Key facts

- **NCT ID:** NCT05546125
- **Lead sponsor:** Pfizer Pharmaceuticals Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-23
- **Primary completion:** 2023-02-27
- **Final completion:** 2023-02-27
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2023-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05546125

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05546125, "a Non-interventional Study of Sildenafil in the Treatment of Pulmonary Arterial Hypertension (PAH) in Adults From China". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05546125. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*